For a small generic company, that could mean big dollars.

So victories for generic companies have been few and far between.

At the least, generic drug companies point to a better pipeline of new products.

The cost of such overhead is often much higher than at generic companies, industry experts say.

Now the generic companies are crying foul because Congress didn't make the change they wanted.

But with an over-the-counter version of the drug just weeks away, the generic companies may have little choice.

Relations are no more cordial among the generic companies themselves.

After that time, other generic companies can also sell the medicine, and prices often plunge.

His father, who is retired, was a pharmaceutical information consultant to generic drug companies.

That could provide an opening for the generic companies.